EAVLA Webinar: Foam Sclerotherapy, Filters, and Stenting

Foam Sclerotherapy Achieves Durable Saphenous Trunk Closure

In 346 patients with primary chronic venous disease, ultrasound guided foam sclerotherapy achieved 77.7 percent five year disease free survival, with trunks up to eight millimeters showing far lower recurrence than larger ones, 91.3 percent versus 46 percent, and high patient satisfaction.

Gunther Tulip and Select Filters: Two-Year Safety Outcomes

This Cook Medical sponsored trial met performance goals for effectiveness and safety in both filter designs, with high retrieval success, low symptomatic pulmonary embolism, and core lab adjudicated perforation criteria showing favorable long term outcomes.

Iliac Vein Stenting Alone Resolves Pelvic Pain

In women with combined iliac vein stenosis and ovarian vein reflux, stenting alone produced sustained pelvic pain relief through 36 months, with only 13 percent needing reintervention, mostly for new contralateral lesions, and no patient requiring ovarian vein embolization.

Foam Sclerotherapy Speeds Venous Leg Ulcer Healing

A randomized trial of 65 patients found foam sclerotherapy of the sub ulcer venous plexus, added to standard compression care, significantly shortened time to complete healing and increased healed ulcer rates at 3 and 6 months versus standard care alone.